Orthofix International | OFIX - Cash And Equivalent


Orthofix International reported $62.86M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
AngioDynamics USD 44.76M 9.33M Feb/2025
AtriCure USD 147.86M 30.07M Sep/2025
Dexcom USD 1.84B 676.7M Sep/2025
EDAP TMS EUR 29.84M 4.35M Dec/2024
Globus Medical USD 229.45M 231.82M Jun/2025
Hologic USD 2.17B 208.5M Dec/2025
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 757.4M 364.2M Sep/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
J&J USD 19.71B 1.48B Dec/2025
Medtronic USD 1.28B 9M Sep/2025
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 62.86M 2.75M Sep/2025
Plus Therapeutics USD 8.55M 2.45M Dec/2023
STAAR Surgical USD 176.16M 9.02M Sep/2025
Stryker USD 4.01B 755M Dec/2025
Surmodics USD 36.11M 11.81M Sep/2024
Tandem Diabetes Care USD 91.95M 27.83M Sep/2025
Teleflex USD 354M 100.3M Sep/2025
Veracyte USD 315.57M 96.07M Sep/2025
Zimmer Biomet Holdings USD 1.29B 735.8M Sep/2025